Home / Lab Basics / Bloodwork conversations

What bloodwork clinicians typically discuss before peptide consultations

How to read this article

This is the piece I wish I had read before my first clinician conversation. I walked in vaguely aware of what a “CBC” was and blank on almost everything else, which meant I spent the first ten minutes of the visit catching up on vocabulary rather than having the conversation I came for.

Every lab discussed below is standard. None of them is specific to peptides, and that is the point: the work-up that happens before a peptide consultation is, in most cases, the same work-up any careful clinician would order before a new conversation about anything going into your body. A clinician who orders a baseline is doing their job. A clinician who does not is saving you money in the short term and borrowing trouble in the long term.

This article describes what these labs are. It does not describe what to do if yours comes back abnormal. That is a conversation for the clinician who ordered the test.

General health baseline

Almost every consultation starts here. Two standard panels cover most of the ground.

Complete Blood Count (CBC)

A CBC measures the cells in your blood: red blood cells, white blood cells, platelets, and several derived values (hematocrit, hemoglobin, mean cell volume, and so on). It answers basic questions about whether the bone marrow is producing cells normally, whether there is evidence of infection or inflammation that shows up in white cell counts, and whether there is an anemia or clotting concern.

Peptides do not directly change most of what a CBC measures. The reason it shows up in the baseline is that clinicians like to know the baseline before introducing anything new, so that if something changes later, there is a reference point to compare against.

Comprehensive Metabolic Panel (CMP)

A CMP covers electrolytes (sodium, potassium, chloride, bicarbonate), kidney function (creatinine, BUN, estimated GFR), liver function (ALT, AST, bilirubin, alkaline phosphatase), glucose, calcium, and total protein/albumin. Fourteen or so values on one panel, giving a wide-angle view of kidney, liver, and basic metabolism.

Kidney and liver function matter for any compound that will be processed by those organs, which is essentially everything. Baseline liver enzymes and baseline creatinine are the minimum a thoughtful clinician wants in hand before starting a conversation.

Metabolic markers

For any peptide conversation that touches weight, appetite, insulin sensitivity, or metabolic health, a clinician will typically look at a deeper metabolic picture than the CMP gives.

Fasting glucose

Glucose measured after an overnight fast. A single value. Useful, but limited.

HbA1c

Glycated hemoglobin. A three-month average of blood sugar exposure, expressed as a percentage. More informative than a single glucose measurement because it smooths out day-to-day noise. HbA1c is the standard screening measure for pre-diabetes and diabetes, and it matters in any conversation about GLP-1 agonists and related compounds.

Fasting insulin

Less commonly ordered as part of a standard baseline, but it comes up in conversations about insulin sensitivity. Paired with fasting glucose, insulin can be used to calculate HOMA-IR, a rough estimate of insulin resistance.

Lipid panel

Total cholesterol, LDL, HDL, triglycerides, and often non-HDL cholesterol or apolipoprotein B on a more detailed panel. Lipid profile interacts with metabolic health in ways that matter for any conversation about weight or glycemic-acting compounds.

The reason a clinician cares about metabolic markers before a GLP-1 conversation is not that the peptide is risky for metabolism; it is that the peptide class has large metabolic effects, and the clinician wants to know where the patient is starting from so they can recognize a meaningful change later.

Hormonal baseline

For peptides acting on the growth-hormone axis, thyroid function, or reproductive hormones, a hormonal baseline is the centerpiece of the work-up.

IGF-1

Insulin-like Growth Factor 1 is the standard downstream marker for growth hormone signalling. When a clinician talks about a GHRH analog like Tesamorelin, or a secretagogue like Sermorelin or Ipamorelin, IGF-1 is the marker that typically defines the conversation. IGF-1 is its own subject and has its own article on this site.

Total and free testosterone

Serum testosterone is relevant in any conversation where anabolic signalling is on the table. Total testosterone is straightforward; free testosterone (the fraction not bound to sex hormone binding globulin) is what is actually biologically available. A thoughtful clinician looks at both.

Thyroid panel

TSH, free T4, and (on a deeper panel) free T3 and reverse T3. Thyroid interacts with almost every metabolic conversation. A TSH alone is the bare minimum; a full thyroid panel is more informative.

Estradiol, cortisol, DHEA-S

Depending on the specific conversation, these may come up. Estradiol in the context of anabolic signalling and body composition. Cortisol when sleep, stress, or adrenal-axis questions are part of the picture. DHEA-S as a broader adrenal baseline.

Hormonal labs are the one category where timing matters most. Morning draws, fasting, and consistent timing across repeat draws are the standard because hormones rise and fall across the day and the week. A lab drawn at 4pm is not the same as the same lab drawn at 8am, and a clinician ordering hormonal baselines will usually specify morning and fasted.

Inflammation markers

hs-CRP, or high-sensitivity C-reactive protein, is the standard inflammation marker that comes up in most comprehensive work-ups. CRP measures a general inflammatory signal from the liver; the “hs” version picks up lower levels than the older assay could, which is what makes it useful as a chronic inflammation baseline rather than just an acute infection marker.

hs-CRP is not peptide-specific. It is a general health marker. It shows up in the baseline because chronic inflammation modifies how a body responds to nearly anything introduced into it, and because persistent elevation is its own signal worth a separate conversation regardless of peptide context.

Beyond hs-CRP, more detailed work-ups can include ESR (erythrocyte sedimentation rate), ferritin (which doubles as an iron-stores marker and an acute-phase reactant), and homocysteine. These are usually clinician-selected based on the specific conversation.

Markers specific to specific peptide classes

Beyond the general baseline, certain peptide classes have their own relevant markers. This is not an order list; it is a vocabulary guide.

GLP-1 receptor agonists (Semaglutide, Tirzepatide, Retatrutide)

Beyond the metabolic baseline, lipase (a pancreatic enzyme) sometimes comes up because rare pancreatitis has been reported with this class. Thyroid function also matters because of a labelled consideration around a specific thyroid cancer (medullary thyroid cancer). A clinician familiar with the class will know when to check.

Growth hormone axis (Tesamorelin, Sermorelin, Ipamorelin, CJC-1295)

IGF-1 is central, as noted above. Fasting glucose and HbA1c matter because growth-hormone-axis signalling can affect glucose handling. Lipids, because some of these peptides have visible effects on visceral fat and lipid profile.

Thymosin family (Thymosin Alpha-1, TB-500)

A general health baseline (CBC, CMP) is the main piece. Specific markers depend heavily on the conversation, since the human evidence base for different thymosin peptides varies widely.

Melanocortin agonists (PT-141, Afamelanotide)

Blood pressure monitoring tends to matter more than labs for this class. A baseline blood pressure reading and, on a more complete work-up, a cardiovascular-focused discussion.

Why this is a conversation, not a self-serve checklist

I think the single most important framing shift a reader can make is this: bloodwork is information, not instruction. A lab number is a data point. A lab panel is a cluster of data points. What those data points mean depends on the person they were drawn from, the question being asked, and the clinical picture the clinician is building.

A fasting glucose of 105 mg/dL reads differently in a lean thirty-year-old with an active exercise history than it does in someone whose family history includes early diabetes. A TSH at the upper end of the reference range means different things depending on what the free T4 is doing. An IGF-1 value in the middle of the reference range can be healthy, or it can be the early signal of a specific conversation worth having. The numbers alone do not tell you.

This is why the labs are the start of a conversation, not the output of one. The direct-to-consumer lab market has trained readers to think of themselves as the reader of their own data. I think that framing does more harm than good when the labs being read are nuanced and the stakes are real. A clinician is not a gatekeeper between you and your data. A clinician is someone whose job is to know what one data point means given the other forty data points.

Questions to ask your clinician

If you are going into a peptide consultation, these are the questions I would walk in with. They are not test orders; they are invitations for your clinician to walk you through their own reasoning.

1. Before we discuss any peptide, what baseline bloodwork would you want to see, and why?
2. If a specific peptide is on the table, are there additional labs you would add for that class, and what would you be looking for?
3. How do you want to space follow-up bloodwork if I eventually start a prescribed preparation?
4. Are there any of my current medications or supplements that would interact with the labs or with the peptide class we are discussing?
5. If any of my baseline labs come back outside the usual range, what conversations do those findings open up independently of the peptide question?
6. What would you consider a good reason to pause a conversation about peptides based on what a baseline shows?

What to do next

Sources

• American Association for Clinical Chemistry. Standard panels (CBC, CMP) reference material.
• Endocrine Society clinical practice guidelines on growth hormone testing and IGF-1 measurement.
• American Diabetes Association. HbA1c standards for diabetes diagnosis and monitoring.
• United States Pharmacopeia and laboratory-medicine standard references for hs-CRP interpretation.
• Labeled considerations and monitoring recommendations for FDA-approved peptides in each class referenced (Tesamorelin, Semaglutide, Tirzepatide, Afamelanotide).

References are illustrative. None of the content above is a substitute for an order placed by a licensed clinician.

Related reading